A psychometric evaluation of the Chinese Impact of Vision Impairment (C-IVI) questionnaire in an adult cohort with high myopia using Rasch analysis
PLOS One · 2025
DOI: 10.1371/journal.pone.0327708 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wei Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Aier Academy of Ophthalmology, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Psychometrics, Quality of Life, Myopia, Vision Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technology Innovation Program of Hunan Province, China.
Abstract (Originalsprache)
Purpose
A psychometric evaluation of the Chinese Impact of Vision Impairment (C-IVI) questionnaire in an adult cohort with high myopia using Rasch Analysis and determination of the relationship between vision-related quality-of-life (VRQoL) and myopia macular degeneration (MMD).
Methods
We used the baseline visit data of the AIER-Singapore Eye Research Institute (SERI) High Myopia Adult Cohort Study. VRQoL was assessed using the 28-item C-IVI. Rasch analysis was conducted to evaluate the overall C-IVI and domain scores (‘Mobility and independence’—MB, ‘Reading and accessing information’—RD, and ‘Emotional well-being’—EWB), including response category functioning, precision, unidimensionality, targeting, and differential item functioning (DIF). The criterion validity, C-IVI’s ability to distinguish participants based on severity of vision impairment (VI), spherical equivalent (SER), and the presence of MMD were analyzed using ANOVA and pairwise t-tests.
Results
There were 431 participants, with mean (SD) age of 42.2 (7.1) years, SER of −8.3 (3.8) D, and visual acuity of 0.1 (0.2) LogMAR. Of these, 15.8% presented MMD, 79.4%, 13.5%, 7.0%, and 0.2% had no, mild, moderate, and severe VI, respectively. Response thresholds were ordered for the overall and three domains. The overall range-based precision was 0.94, and 0.80 for each domain. The three domains demonstrated unidimensionality. DIF was uniform in overall and EWB, but not the MB and RD domains. Person estimates decreased with increasing VI severity, worsening SER, and presenting MMD (all p < 0.05) for the overall and domain scores.
Conclusions
The C-IVI questionnaire is a valid and reliable tool for assessing VRQoL in adults with high myopia in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Aier Academy of Ophthalmology, Central South University, Changsha, China.
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
- Duke-NUS Medical School, Singapore.
- Changsha Aier Eye Hospital, Changsha, China.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
- University of Melbourne, Australia.
ORCID-Profile: Wei Pan, Ryan E K Man, Seang-Mei Saw
Förderung
- the Science and Technology Innovation Program of Hunan Province, China
Zitieren
APA
Pan, W., Man, R. E. K., Fenwick, E. K., Hu, Z., Jiang, Y., Tan, H., Chen, Z., Hoang, Q. V., Saw, S. M., Lamoureux, E. L., Lan, W., & Yang, Z. (2025). A psychometric evaluation of the Chinese Impact of Vision Impairment (C-IVI) questionnaire in an adult cohort with high myopia using Rasch analysis. PLOS One. https://doi.org/10.1371/journal.pone.0327708
Vancouver
Pan W, Man REK, Fenwick EK, Hu Z, Jiang Y, Tan H, et al. A psychometric evaluation of the Chinese Impact of Vision Impairment (C-IVI) questionnaire in an adult cohort with high myopia using Rasch analysis. PLOS One. 2025. doi:10.1371/journal.pone.0327708
BibTeX
@article{Pan2025,
author = {Pan, Wei and Man, Ryan E K and Fenwick, Eva K and Hu, Ziqi and Jiang, Yanfeng and Tan, Huanhuan and Chen, Zhongping and Hoang, Quan V and Saw, Seang-Mei and Lamoureux, Ecosse L and Lan, Weizhong and Yang, Zhikuan},
title = {A psychometric evaluation of the Chinese Impact of Vision Impairment (C-IVI) questionnaire in an adult cohort with high myopia using Rasch analysis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327708}
}
EUVIMED